University of Colorado, Denver
The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g. clinical features, genetic variants, and/or biologic markers) between other forms of ILD (e.g. idiopathic pulmonary fibrosis, IPF) and subclinical RA-ILD that places individuals at risk for the development of lung disease.
Rheumatoid Arthritis
Interstitial Lung Disease
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 750 participants |
| Official Title : | Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease |
| Actual Study Start Date : | 2017-06-22 |
| Estimated Primary Completion Date : | 2027-06 |
| Estimated Study Completion Date : | 2027-06 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 45 Years to 90 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of Colorado - Anschutz Medical Campus
Aurora, Colorado, United States, 80045